About Us
Coming Soon: Ottawa’s Solventless Therapeutics, R&D, Cultivation & Manufacturing Hub Engineered for Global Health Innovation, Designed to GACP, EU-GMP Standards
CannaGenetics is building Canada’s premiere fully integrated Solventless therapeutics, R&D, cultivation, and manufacturing hub in Ottawa.
Our planned 42,900 sq. ft. flagship facility is designed to meet EU-GMP and GACP standards, supporting the development of clean label cannabinoid formulations for both human and veterinary health applic
CannaGenetics is building Canada’s premiere fully integrated Solventless therapeutics, R&D, cultivation, and manufacturing hub in Ottawa.
Our planned 42,900 sq. ft. flagship facility is designed to meet EU-GMP and GACP standards, supporting the development of clean label cannabinoid formulations for both human and veterinary health applications.
Purpose built from the ground up, the site integrates:
- Precision controlled, no soil aeroponics for pharmaceutical grade cultivation
- ISO 7 cleanroom manufacturing zones for formulation and QA/QC
- 100% Solventless extraction equipment for high bioavailability therapeutic oils
- A fully traceable seed to SKU platform supporting batch control, export documentation, and IP licensing
- Secure, automated environments engineered for regulatory compliance and efficiency
This advanced infrastructure positions CannaGenetics at the intersection of cannabinoid science, therapeutic innovation, and global export opportunity, all from within Canada’s capital.
Our Vision: Cannabis & Healing
To redefine the future of cannabinoid medicine by building Canada’s premiere fully integrated, pharmaceutical grade platform for both human and veterinary therapeutics.
Powered by solventless innovation, validated through clinical data, and aligned with global export standards, we are committed to setting a new benchmark in cannabinoid sc
To redefine the future of cannabinoid medicine by building Canada’s premiere fully integrated, pharmaceutical grade platform for both human and veterinary therapeutics.
Powered by solventless innovation, validated through clinical data, and aligned with global export standards, we are committed to setting a new benchmark in cannabinoid science.
We envision a world where clean label cannabinoid formulations are approved, trusted, and widely accessible improving quality of life, supporting health system transformation, and elevating Canada’s leadership in therapeutic cannabis innovation.
What Sets CannaGenetics Apart
What Sets CannaGenetics Apart
- We’re not just building another cannabis facility, we’re engineering a life sciences platform designed to deliver real therapeutic impact and long term economic value.
No soil aeroponics = not soil or coco Enabling clean, efficient, pharmaceutical grade inputs with 90% water savings and fully traceable proprietary grow recipes.
- Solve
- We’re not just building another cannabis facility, we’re engineering a life sciences platform designed to deliver real therapeutic impact and long term economic value.
No soil aeroponics = not soil or coco Enabling clean, efficient, pharmaceutical grade inputs with 90% water savings and fully traceable proprietary grow recipes.
- Solventless from start to finish Eliminating CO₂, ethanol, and hydrocarbon solvents in favor of pure, high bioavailability formulations that meet global expectations for clean medicine.
- Clinical first formulation strategy Built around real world use cases, and early stage clinical validation.
- Veterinary innovation built in one of the only Canadian platforms actively developing hemp compliant companion animal formulations aligned with Health Canada’s CBD vet consultation.
- Designed for export, not just domestic rec and medical markets Planned facility built to EU-GMP and GACP specs from the ground up, ready for future compliance driven global licensing and distribution.
New Construction Design As Per GACP & EU-GMP Specifications
Precision Aeroponics Facility
Phase 1 construction of our state of the art, 42,900 sq.ft Double stacked indoor precision aeroponcs facility at the Ottawa West Carp Airport.
Property Owned Outright:
•Situated on fully secured airport perimeter
•Plans ready to build a state of the art 42,900 sq. ft precision aeroponics facility
•Secured 10.45 acres on apron of Ottawa West airport
• Capacity to triple the initial planned footprint through expansion on current property
Strategic Location: • Access to the National Capital Region’s high tech employment pool • Quick facility response times • Located in proximity to the business district significantly reducing
travel and commuting expenses as experienced by most rural producers
Full seed to sale capabilities with processing on site : Propagate, Cultivate, Process, Package, Distribute
Precision Aeroponics Facility
CannaGenetics have secured all required zoning approvals from the City of Ottawa, and clearance from Health Canada to proceed with the construction of our inaugural cultivation and manufacturing facility.
Our Ottawa location, a bustling business and tech hub, lends us proximity to other industry innovators.
Referred to as "Silicon Valley North," Ottawa's vibrant ecosystem fosters entrepreneurial growth.
Our strategic location grants us access to high-tech talent and enables swift facility response times.
Proximity to the business district aids in reducing travel expenses, ensuring cost-effectiveness without quality compromise.
Furthermore, our location will enhance partnerships with local businesses and community engagement, a critical aspect of CannaGenetics' ethos. (Pause)
As a licensed producer in Canada, we're eligible to create a "farmgate" center on our premises, catering to on-site sales and the burgeoning "Cannabis tourism".
Processing
As part of our manufacturing platform, CannaGenetics will integrate advanced solventless extraction systems that preserve the full spectrum of native cannabinoids, terpenes, and minor compounds, without the use of chemical solvents or high temperature distillation.
This process ensures exceptional product integrity, sensory fidelity, and batch to batch consistency, making it ideal for both pharmaceutical grade API development and clinical ready therapeutic formulations.
By avoiding traditional ethanol, hydrocarbon, or CO₂ based methods, our platform will deliver clean label, full spectrum cannabinoid inputs that align with the most stringent expectations for quality, safety, and therapeutic performance, especially in medical, wellness, and veterinary channels.
Servicing All Markets
Health Canada Licensing Awaiting Final Construction and Inspection
Health Canada Licensing Awaiting Final Construction and Inspection
- Standard Cultivation
- Processing
- Federal Sales - Medical
Post Construction Applications to be filed:
- Export License (Medical / R&D)
- Research licence
- Provincial and territorial authorized retailer (farmgate)
Dedicated to Quality
Health Canada Licensing Awaiting Final Construction and Inspection
Conservation of Resources, Product Safety, Quality & Transparency is what CannaGenetics stand for.
No Soil or Waste (100%)
No Pesticides (100%)
Eco-Friendly Reductions In Water (90%)
Eco-Friendly Reductions In Nutrients (60%)
Pure Water: No Heavy Metals, No Pathogens, No Antibiotics, No Hormones
CannaGenetics' approach to cannabis producti
Conservation of Resources, Product Safety, Quality & Transparency is what CannaGenetics stand for.
No Soil or Waste (100%)
No Pesticides (100%)
Eco-Friendly Reductions In Water (90%)
Eco-Friendly Reductions In Nutrients (60%)
Pure Water: No Heavy Metals, No Pathogens, No Antibiotics, No Hormones
CannaGenetics' approach to cannabis production using no soil precision aeroponics to eliminate high overhead costs and wasteful use of natural resources associated with traditional soil-based production, ensuring a clean and controlled environment for medical grade cannabis production.
CANNA WORLD PHARMA - Nature's medicine, perfected
CANNA WORLD PHARMA - Nature's medicine, perfected
CannaGenetics' medical division, Canna World Pharma, aims to produce a new subset of medical grade infused cannabis products and high psychoactive pharmaceutical API cannabis oil in compliance with GACP & EU GMP certification. We believe that the future of the cannabis industry lies in developing novel products that cater to the health an
CannaGenetics' medical division, Canna World Pharma, aims to produce a new subset of medical grade infused cannabis products and high psychoactive pharmaceutical API cannabis oil in compliance with GACP & EU GMP certification. We believe that the future of the cannabis industry lies in developing novel products that cater to the health and wellness sector, where there is a growing demand for natural and alternative therapies. We plan to generate revenue through the sale of our pharma grade cannabis products to the medical and wellness sectors in Canada and internationally. Our long-term strategy involves partnering in R&D initiatives and clinical trials to develop novel cannabis-based products that cater to the health and wellness sector. We plan to collaborate with leading universities and research institutions to conduct extensive clinical trials to validate the efficacy of our products.